Bjørn Naume

Bjørn Naume is a Professor in the Department of Oncology at the University of Oslo. His work focuses on breast cancer research, including clinical trials, genomic analysis, and molecular diagnostics. He has contributed to studies on disseminated tumor cells, treatment efficacy, and prognostic biomarkers in breast cancer. His research often involves collaborations with international teams and addresses translational aspects of oncology.

• Key areas: Breast cancer biology, clinical trials, genomic profiling, and patient pathways.
• Notable contributions include studies on Prosigna test applications, triple-negative breast cancer immunotherapy, and tamoxifen metabolite prognostics.

His publications highlight advancements in understanding breast cancer subtypes, treatment responses, and long-term patient outcomes. Collaborations with institutions like Oslo University Hospital and international consortia further emphasize his role in advancing oncological care.